Human immunoglobulin, hepatitis B (Shanghai Institute of Biological Products)

乙型肝炎人免疫球蛋白

Report date: 2022/02/28 17:59:08

Base Information

Drug NameHuman immunoglobulin, hepatitis B (Shanghai Institute of Biological Products)
Drug Alias NameShang Sheng Gan Di上生甘迪
ClassificationBiologics > Protein drugs > ImmunoglobulinBiologics > Blood components
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsHepatitis B
Approved Indications in ChinaHepatitis B
Original Approved Country/TerritoryMainland China
Original Approved Date1999/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Institute of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Institute of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis B
Inactive IndicationsN/A

Other Information

ATC CodeJ06BB04
Related LinksN/A